Don’t miss the latest developments in business and finance.

Cadila Healthcare recieves EIR for its Moraiya manufacturing facility

Image
Capital Market
Last Updated : Jul 08 2016 | 3:13 PM IST

For inspection carried out between 28 August and 05 September 2014

Cadila Healthcare announced that the Company's Moraiya manufacturing facility has received an Establishment Inspection Report (EIR) from the USFDA. This receipt of EIR only indicates closure of the inspection points (483s) raised based on the inspection carried out between 28 August 2014 and 05 September 2014. What is "closed" is the initial review that resulted in the warning letter issuance. Though this is a positive step towards the resolution of the warning letter issued by the USFDA, it does not in itself indicate resolution of the warning letter. The company is in constant follow up with the USFDA for resolution of the warning letter.

Powered by Capital Market - Live News

Also Read

First Published: Jul 08 2016 | 2:57 PM IST

Next Story